Skip to main content
Enter the terms you wish to search for.
Select Search Option
This Site
All WCM Sites
Directory
Menu
Weill Cornell Medicine
Care
Discover
Teach
Jill Roberts Center for Inflammatory Bowel Disease
Explore this Website
Home
About Us
Toggle About Us menu options
Clinical Staff
Research Staff
Contact Us
Newsworthy
Toggle Newsworthy menu options
News and Announcements
Patient Care
Toggle Patient Care menu options
Clinical Services
FAQs
For Your Visit
COVID-19 Information
Nutrition Science
Toggle Nutrition Science menu options
Nutrition FAQs
Food Intolerances
News in IBD Nutrition
Research and Clinical Trials
Toggle Research and Clinical Trials menu options
Clinical Trials
Publications
Weill Cornell Medicine
Care
Discover
Teach
Home
About Us
Newsworthy
Patient Care
Nutrition Science
Research and Clinical Trials
Home
Publications
Publications
Clinical Trials
Publications
Publications
Found 46 results
Author
Title
Type
[
Year
]
Filters:
First Letter Of Last Name
is
P
[Clear All Filters]
2019
Patel A
,
Namn Y
,
Shah SL
,
Scherl E
,
Wan DW
. 2019.
Takotsubo cardiomyopathy after an upper and lower endoscopy: a case report and review of the literature.
.
J Med Case Rep. 13(1):81.
2018
Dulai PS
,
Boland BS
,
Singh S
,
Chaudrey K
,
Koliani-Pace JL
,
Kochhar G
,
Parikh MP
,
Shmidt E
,
Hartke J
,
Chilukuri P
et al.
. 2018.
Development and Validation of a Scoring System to Predict Outcomes of Vedolizumab Treatment in Patients With Crohn's Disease.
.
Gastroenterology. 155(3):687-695.e10.
Dulai PS
,
Boland BS
,
Singh S
,
Chaudrey K
,
Koliani-Pace JL
,
Kochhar G
,
Parikh MP
,
Shmidt E
,
Hartke J
,
Chilukuri P
et al.
. 2018.
Development and Validation of a Scoring System to Predict Outcomes of Vedolizumab Treatment in Patients With Crohn's Disease.
.
Gastroenterology. 155(3):687-695.e10.
Castellanos JG
,
Woo V
,
Viladomiu M
,
Putzel G
,
Lima S
,
Diehl GE
,
Marderstein AR
,
Gandara J
,
Perez AR
,
Withers DR
et al.
. 2018.
Microbiota-Induced TNF-like Ligand 1A Drives Group 3 Innate Lymphoid Cell-Mediated Barrier Protection and Intestinal T Cell Activation during Colitis.
.
Immunity. 49(6):1077-1089.e5.
Castellanos JG
,
Woo V
,
Viladomiu M
,
Putzel G
,
Lima S
,
Diehl GE
,
Marderstein AR
,
Gandara J
,
Perez AR
,
Withers DR
et al.
. 2018.
Microbiota-Induced TNF-like Ligand 1A Drives Group 3 Innate Lymphoid Cell-Mediated Barrier Protection and Intestinal T Cell Activation during Colitis.
.
Immunity. 49(6):1077-1089.e5.
Narula N
,
Peerani F
,
Meserve J
,
Kochhar G
,
Chaudrey K
,
Hartke J
,
Chilukuri P
,
Koliani-Pace J
,
Winters A
,
Katta L
et al.
. 2018.
Vedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY Consortium.
.
Am J Gastroenterol. 113(9):1345.
Narula N
,
Peerani F
,
Meserve J
,
Kochhar G
,
Chaudrey K
,
Hartke J
,
Chilukuri P
,
Koliani-Pace J
,
Winters A
,
Katta L
et al.
. 2018.
Vedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY Consortium.
.
Am J Gastroenterol. 113(9):1345.
2017
Viladomiu M
,
Kivolowitz C
,
Abdulhamid A
,
Dogan B
,
Victorio D
,
Castellanos JG
,
Woo V
,
Teng F
,
Tran NL
,
Sczesnak A
et al.
. 2017.
IgA-coated enriched in Crohn's disease spondyloarthritis promote T17-dependent inflammation.
.
Sci Transl Med. 9(376)
Jacob V
,
Crawford C
,
Cohen-Mekelburg S
,
Viladomiu M
,
Putzel GG
,
Schneider Y
,
Chabouni F
,
OʼNeil S
,
Bosworth B
,
Woo V
et al.
. 2017.
Single Delivery of High-Diversity Fecal Microbiota Preparation by Colonoscopy Is Safe and Effective in Increasing Microbial Diversity in Active Ulcerative Colitis.
.
Inflamm Bowel Dis. 23(6):903-911.
Jacob V
,
Crawford C
,
Cohen-Mekelburg S
,
Viladomiu M
,
Putzel GG
,
Schneider Y
,
Chabouni F
,
OʼNeil S
,
Bosworth B
,
Woo V
et al.
. 2017.
Single Delivery of High-Diversity Fecal Microbiota Preparation by Colonoscopy Is Safe and Effective in Increasing Microbial Diversity in Active Ulcerative Colitis.
.
Inflamm Bowel Dis. 23(6):903-911.
2015
Huang C
,
Haritunians T
,
Okou DT
,
Cutler DJ
,
Zwick ME
,
Taylor KD
,
Datta LW
,
Maranville JC
,
Liu Z
,
Ellis S
et al.
. 2015.
Characterization of genetic loci that affect susceptibility to inflammatory bowel diseases in African Americans.
.
Gastroenterology. 149(6):1575-86.
Gerbarg PL
,
Jacob VE
,
Stevens L
,
Bosworth BP
,
Chabouni F
,
DeFilippis EM
,
Warren R
,
Trivellas M
,
Patel PV
,
Webb CD
et al.
. 2015.
The Effect of Breathing, Movement, and Meditation on Psychological and Physical Symptoms and Inflammatory Biomarkers in Inflammatory Bowel Disease: A Randomized Controlled Trial.
.
Inflamm Bowel Dis. 21(12):2886-96.
2013
Scher JU
,
Sczesnak A
,
Longman RS
,
Segata N
,
Ubeda C
,
Bielski C
,
Rostron T
,
Cerundolo V
,
Pamer EG
,
Abramson SB
et al.
. 2013.
Expansion of intestinal Prevotella copri correlates with enhanced susceptibility to arthritis.
.
Elife (Cambridge). 2:e01202.
2009
Murphy SJ
,
Wang L
,
Anderson LA
,
Steinlauf A
,
Present DH
,
Mechanick JI
. 2009.
Withdrawal of corticosteroids in inflammatory bowel disease patients after dependency periods ranging from 2 to 45 years: a proposed method.
.
Aliment Pharmacol Ther. 30(10):1078-86.
2008
Marion JF
,
Waye JD
,
Present DH
,
Israel Y
,
Bodian C
,
Harpaz N
,
Chapman M
,
Itzkowitz S
,
Steinlauf AF
,
Abreu MT
et al.
. 2008.
Chromoendoscopy-targeted biopsies are superior to standard colonoscopic surveillance for detecting dysplasia in inflammatory bowel disease patients: a prospective endoscopic trial.
.
Am J Gastroenterol. 103(9):2342-9.
Poppers DM
,
Scherl EJ
. 2008.
Prophylaxis against Pneumocystis pneumonia in patients with inflammatory bowel disease: toward a standard of care.
.
Inflamm Bowel Dis. 14(1):106-13.
2007
Longman RS
,
Braun D
,
Pellegrini S
,
Rice CM
,
Darnell RB
,
Albert ML
. 2007.
Dendritic-cell maturation alters intracellular signaling networks, enabling differential effects of IFN-alpha/beta on antigen cross-presentation.
.
Blood. 109(3):1113-22.
Decalf J
,
Fernandes S
,
Longman R
,
Ahloulay M
,
Audat F
,
Lefrerre F
,
Rice CM
,
Pol S
,
Albert ML
. 2007.
Plasmacytoid dendritic cells initiate a complex chemokine and cytokine network and are a viable drug target in chronic HCV patients.
.
J Exp Med. 204(10):2423-37.
2006
Otani T
,
Yamaguchi K
,
Scherl E
,
Du B
,
Tai H-H
,
Greifer M
,
Petrovic L
,
Daikoku T
,
Dey SK
,
Subbaramaiah K
et al.
. 2006.
Levels of NAD(+)-dependent 15-hydroxyprostaglandin dehydrogenase are reduced in inflammatory bowel disease: evidence for involvement of TNF-alpha.
.
Am J Physiol Gastrointest Liver Physiol. 290(2):G361-8.
2004
Steinlauf AF
,
Present DH
. 2004.
Medical management of the pregnant patient with inflammatory bowel disease.
.
Gastroenterol Clin North Am. 33(2):361-85,xi.
2001
Persley K
,
Scherl E
,
Rubin P
. 2001.
Avoidance of steroids by the early use of infliximab and 6-mercaptopurine in an adolescent with active Crohn's colitis.
.
Am J Gastroenterol. 96(12):3444-5.
« first
‹ previous
1
2
(current)